Author + information
- Received August 28, 1989
- Revision received November 16, 1989
- Accepted November 29, 1989
- Published online May 1, 1990.
- ↵*Address for reprints: Akito Yatani, MD, The First Department of Internal Medicine, Kobe University School of Medicine, 7-5-1, Kusunoki-cho, Chuoku, Kobe 650, Japan.
The effects of substance P, a putative central and peripheral neurotransmitter, on coronary vasculature and its mechanisms were studied in 31 anesthetized open chest dogs. Without coronary stenosis, intracoronary infusion of substance P (0.001 to 1 pmol/kg per min) for 40 s increased coronary blood flow up to 173 ± 10.7% in dose-dependent fashion. Application of coronary stenosis created by an inflated intraluminal microballoon that preserved active vasomotion of the stenosed segment produced a pressure gradient of 34 ± 2 mm Hg, a decrease in rest coronary blood flow of 21 ± 1.6% and significant depression of the rate of rise in left ventricular pressure (dP/dt). During coronary stenosis, substance P increased coronary blood flow up to 150 ± 9.4%, lowered mean distal coronary pressure and decreased stenosis resistance in dose-dependent fashion.
After endothelial denudation of the proximal part of the coronary artery, the substance P-induced increments in coronary blood flow during coronary stenosis were abolished. In vitro measurements of isometric tension from both intact and denuded portions of coronary arteries confirmed a marked inhibition of substance P-induced relaxation in the denuded segments. These results show the obligatory role of the endothelium in substance P-induced coronary artery dilation. Furthermore, intracoronary infusion of substance P (1 pmol/kg per min) from the site distal to coronary stenosis that precluded the responsiveness of the large coronary artery decreased coronary blood flow by 24 ± 4%, lowered mean distal coronary pressure by 15 ± 1.9 mm Hg and intensified stenosis resistance by 77 ± 7.2%.
Thus, substance P exerts a direct potent dilating effect on both large and small coronary arteries. However, because of its strict endothelium-dependency, this peptide may play a detrimental role in the regulation of coronary blood flow when an atherosclerotic stenotic lesion with endothelial damage or dysfunction is present in the proximal part of the coronary artery.
- Received August 28, 1989.
- Revision received November 16, 1989.
- Accepted November 29, 1989.
- American College of Cardiology Foundation